Phase III trial of rivaroxaban (Xarelto) prematurely stopped Correspondence 20 October 2018 Pages: 2 - 2
Drug interaction test reduces outpatient visits and costs Clinical study 20 October 2018 Pages: 5 - 5
PPIs increase risks of hepatic encephalopathy and mortality Clinical study 20 October 2018 Pages: 8 - 8
Real-world rates and costs of EGFR-TKI-related adverse events Clinical study 20 October 2018 Pages: 9 - 9
Rheumatic immune-related AEs with checkpoint inhibitors Clinical study 20 October 2018 Pages: 10 - 10